Similar articles for PMID: 24002736

Year	Number of Results
1944	1
1950	1
1959	1
1994	1
2000	2
2001	3
2003	4
2004	4
2005	3
2006	3
2007	1
2008	1
2009	4
2010	6
2011	4
2012	9
2013	14
2014	13
2015	5
2016	6
2017	6
2018	3
2019	3
2020	2
2021	2
2022	1
2024	0

1

Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature.

Teplinsky E, Cheung D, Weisberg I, Jacobs RE, Wolff M, Park J, Friedman K, Muggia F, Jhaveri K. Teplinsky E, et al. Breast Cancer Res Treat. 2013 Sep;141(2):167-72. doi: 10.1007/s10549-013-2681-0. Epub 2013 Sep 4. Breast Cancer Res Treat. 2013. PMID: 24002736 Review.

2

A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?

Long M, Jia W, Li S, Jin L, Wu J, Rao N, Feng H, Chen K, Deng H, Liu F, Su F, Song E. Long M, et al. Breast Cancer Res Treat. 2011 Jun;127(3):705-12. doi: 10.1007/s10549-011-1455-9. Epub 2011 Mar 29. Breast Cancer Res Treat. 2011. PMID: 21445574 Clinical Trial.

3

Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.

Steinberg JL, Yeo W, Zhong S, Chan JY, Tam JS, Chan PK, Leung NW, Johnson PJ. Steinberg JL, et al. J Med Virol. 2000 Mar;60(3):249-55. J Med Virol. 2000. PMID: 10630955

4

Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.

Yeo W, Chan PK, Hui P, Ho WM, Lam KC, Kwan WH, Zhong S, Johnson PJ. Yeo W, et al. J Med Virol. 2003 Aug;70(4):553-61. doi: 10.1002/jmv.10430. J Med Virol. 2003. PMID: 12794717

5

[A case of the usage of entecavir to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patient].

Muraoka T, Taira N, Shien T, Doihara H, Takaki A, Miyoshi S. Muraoka T, et al. Gan To Kagaku Ryoho. 2011 Nov;38(11):1861-4. Gan To Kagaku Ryoho. 2011. PMID: 22083198 Japanese.

6

Hepatitis B reactivation during everolimus treatment.

Mir O, Toulmonde M, Coriat R, Ropert S, Loulergue P. Mir O, et al. Acta Oncol. 2016 Dec;55(12):1505-1506. doi: 10.1080/0284186X.2016.1230275. Epub 2016 Oct 24. Acta Oncol. 2016. PMID: 27771976 No abstract available.

7

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK. Yeo W, et al. J Clin Oncol. 2009 Feb 1;27(4):605-11. doi: 10.1200/JCO.2008.18.0182. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075267

8

Hepatitis B Reactivation in a Patient Receiving Chemotherapy for Breast Cancer: A Case Report.

Remo M, Abraham I, Kankanala V, Chacra W, Danciu OC. Remo M, et al. Anticancer Res. 2017 Jul;37(7):3791-3793. doi: 10.21873/anticanres.11755. Anticancer Res. 2017. PMID: 28668876

9

Prevention of Hepatitis B Virus Reactivation With Lamivudine in a Patient With Advanced Renal Cell Carcinoma Treated With Everolimus.

D'Aniello C, Maruzzo M, Basso U. D'Aniello C, et al. Am J Ther. 2016 Jan-Feb;23(1):e300-3. doi: 10.1097/MJT.0000000000000005. Am J Ther. 2016. PMID: 24368609

10

Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.

Wu JM, Huang YH, Lee PC, Lin HC, Lee SD. Wu JM, et al. J Clin Gastroenterol. 2009 May-Jun;43(5):496-8. doi: 10.1097/MCG.0b013e3181945942. J Clin Gastroenterol. 2009. PMID: 19247200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year